Nøhr-Nielsen, Asbjørn <br/><br/>
Pharmacodynamic modelling reveals synergistic interaction between docetaxel and SCO-101 in a docetaxel-resistant triple negative breast cancer cell line.  [electronic resource] 

 -  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences  May 2020 
 - 105315 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0720 
<br/><br/><label>Standard No.: </label>10.1016/j.ejps.2020.105315  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Docetaxel--pharmacology<br/>Drug Interactions<br/>Drug Synergism<br/>Female<br/>Humans<br/>Triple Negative Breast Neoplasms--drug therapy